Artelo Biosciences Inc. [NASDAQ: ARTL] price surged by 11.26 percent to reach at $0.09.
A sum of 4520627 shares traded at recent session while its average daily volume was at 484.40K shares. Artelo Biosciences Inc. shares reached a high of $1.30 and dropped to a low of $0.86 until finishing in the latest session at $0.89.
The average equity rating for ARTL stock is currently 3.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Artelo Biosciences Inc. [ARTL]:
The Average True Range (ATR) for Artelo Biosciences Inc. is set at 0.15 The Price to Book ratio for the last quarter was 0.96, with the Price to Cash per share for the same quarter was set at 0.29.
ARTL Stock Performance Analysis:
Artelo Biosciences Inc. [ARTL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 11.25. With this latest performance, ARTL shares dropped by -10.10% in over the last four-week period, additionally sinking by -7.29% over the last 6 months – not to mention a drop of -58.82% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ARTL stock in for the last two-week period is set at 50.12, with the RSI for the last a single of trading hit 54.95, and the three-weeks RSI is set at 47.49 for Artelo Biosciences Inc. [ARTL]. The present Moving Average for the last 50 days of trading for this stock 1.0080, while it was recorded at 0.7817 for the last single week of trading, and 1.3806 for the last 200 days.
Insight into Artelo Biosciences Inc. Fundamentals:
Return on Total Capital for ARTL is now -120.52, given the latest momentum, and Return on Invested Capital for the company is -81.57. Return on Equity for this stock declined to -81.57, with Return on Assets sitting at -63.15.
Reflecting on the efficiency of the workforce at the company, Artelo Biosciences Inc. [ARTL] managed to generate an average of -$543,044 per employee.Artelo Biosciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.40 and a Current Ratio set at 5.40.
ARTL Stock EPS
With the latest financial reports released by the company, Artelo Biosciences Inc. posted -0.17/share EPS, while the average EPS was predicted by analysts to be reported at -0.42/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 59.50%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ARTL.
Artelo Biosciences Inc. [ARTL] Insider Position Details
There are presently around $0 million, or 0.30% of ARTL stock, in the hands of institutional investors. The top three institutional holders of ARTL stocks are: GOLDMAN SACHS GROUP INC with ownership of 14,223, which is approximately 0% of the company’s market cap and around 7.10% of the total institutional ownership; TOWER RESEARCH CAPITAL LLC (TRC), holding 700 shares of the stock with an approximate value of $1000.0 in ARTL stocks shares; and WELLS FARGO & COMPANY/MN, currently with $0.0 in ARTL stock with ownership of nearly 6.25% of the company’s market capitalization.
Positions in Artelo Biosciences Inc. stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 2 institutional holders increased their position in Artelo Biosciences Inc. [NASDAQ:ARTL] by around 701 shares. Additionally, 1 investors decreased positions by around 799 shares, while 1 investors held positions by with 13,440 shares. The mentioned changes placed institutional holdings at 14,940 shares, according to the latest SEC report filing. ARTL stock had 1 new institutional investments in for a total of 700 shares, while 1 institutional investors sold positions of 799 shares during the same period.